Glen Holland has joined the Boston office of Shott Capital Management as a director. He was most recently with BancBoston Capital, where he worked on the firmís private equity fund portfolio.
Dr. Timothy Wilson has been named a principal in Atlas Ventureís life sciences investment practice. Prior to joining Atlas Venture, Wilson was a senior managing director at Bear Stearns International, where he was responsible for a team based in London and New York that covered the global biotechnology and European health care sectors.
Steve Abbott has been named a director in Deutsche Bank Securities Inc.ís semiconductor investment banking group. Prior to joining Deutsche Bank, Abbott was a principal at Robertson Stephens, where he worked in investment banking, focusing on semiconductor clients. Before joining Robertson, he founded Venture Strategy Partners, a private equity fund.
Tim Bubnack has joined Silicon Valley Bank in its Southern California Venture Capital and Emerging Technology division. Bubnack previously served in senior executive positions at Comerica Ventures Inc. and Comerica Capital.
Matt Miller has joined WaldenVC as a general partner. For the last nine months, he was a WaldenVC venture partner and currently sits on the boards of Visto and Qiva. He also served as CEO of Moai, a WaldenVC portfolio company.
Michael Johnson has joined Commerzbank Securitiesí (ComSec) financial sponsors group, formed earlier this year. Johnson joins ComSec from Nomura Principal Finance Group where he was a transaction director, responsible for originating and executing private equity transactions.